Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac remodeling in systemic hypertension.

Satish Kenchaiah1, Marc A Pfeffer

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. skenchaiah@rics.bwh.harvard.edu

The Medical Clinics of North America
|February 12, 2004
PubMed
Summary

Hypertension causes harmful heart changes, including left ventricular hypertrophy (LVH). Antihypertensive therapies can reverse these changes, improving heart function and reducing cardiovascular risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial.

Journal of cardiac failure·2025
Same author

Response to Cleland and Anzar.

Clinical trials (London, England)·2025
Same author

Aspirin in primary prevention: Undue reliance on an uninformative trial led to misinformed clinical guidelines.

Clinical trials (London, England)·2025
Same author

Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 Trials.

Journal of the American College of Cardiology·2025
Same author

Multiparametric Assessment of Right Ventricular Dysfunction in Heart Failure: An Analysis From PARAGON-HF.

Journal of the American Heart Association·2024
Same author

Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data.

European journal of heart failure·2024

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiac Pathophysiology

Background:

  • Hypertension is linked to adverse cardiac structural and functional changes.
  • These include left atrial enlargement, left ventricular hypertrophy (LVH), myocardial fibrosis, and impaired systolic/diastolic function.
  • Both hemodynamic and nonhemodynamic factors contribute to these changes.

Purpose of the Study:

  • To review the evidence on antihypertensive therapy's role in preventing and reversing cardiac changes associated with hypertension.
  • To highlight the importance of preventing LVH in hypertensive patients.
  • To discuss future therapeutic targets for hypertensive heart disease.

Main Methods:

  • Review of experimental and clinical studies.
  • Analysis of data from small and large clinical trials on antihypertensive therapies.

Related Experiment Videos

  • Evaluation of the impact of therapy on LVH, myocardial fibrosis, cardiac function, and cardiovascular outcomes.

    • Main Results:

    • Various antihypertensive therapies are effective in preventing and regressing LVH and myocardial fibrosis.
    • Reversal of LVH is associated with improved cardiac function and reduced cardiovascular event risk.
    • Prevention of LVH is a critical goal in managing hypertension.

    Conclusions:

    • Antihypertensive therapy plays a key role in managing hypertensive heart disease by optimizing blood pressure and regressing LVH.
    • Future therapeutic strategies should aim for myocardial fibrosis regression, LA size normalization, and improved LV diastolic function.
    • Comprehensive management of hypertensive heart disease requires addressing both blood pressure control and cardiac remodeling.